Global Medical REIT Holds Annual Stockholder Meeting

Global Medical REIT ( (GMRE) ) has issued an update.

On May 14, 2025, Global Medical REIT Inc. conducted its annual meeting where stockholders elected seven directors to the board, approved executive compensation, and ratified Deloitte & Touche LLP as the accounting firm for 2025. These decisions reflect the company’s ongoing governance and operational strategies, potentially impacting its market positioning and stakeholder confidence.

The most recent analyst rating on (GMRE) stock is a Buy with a $11.75 price target. To see the full list of analyst forecasts on Global Medical REIT stock, see the GMRE Stock Forecast page.

Spark’s Take on GMRE Stock

According to Spark, TipRanks’ AI Analyst, GMRE is a Neutral.

Global Medical REIT’s overall score is impacted by strong financials, particularly in revenue growth and cash flow, but offset by low profitability metrics and high valuation concerns. Technical indicators suggest weak momentum. The mixed sentiment from the earnings call, with strategic positives counterbalanced by revenue and tenant issues, contributes to a cautious outlook.

To see Spark’s full report on GMRE stock, click here.

More about Global Medical REIT

Average Trading Volume: 564,618

Technical Sentiment Signal: Sell

Current Market Cap: $492.6M

See more data about GMRE stock on TipRanks’ Stock Analysis page.